In this interview conducted at Pittcon 2023 in Philadelphia, Pennsylvania, we spoke to 2023’s recipient of the Ralph N. Adams Award in Analytical Chemistry, Professor Joseph Wang, about the ...

The global biosensors market is driven by rapid adoption in healthcare, biopharma, environmental monitoring, and industrial applications. Rising chronic disease prevalence, point-of-care diagnostics, ...

DNA can signal the presence of or predisposition to a slew of diseases, including cancer. The ability to flag down these clues, known as biomarkers, allows medical professionals to make critical early ...

Dublin, Dec. 02, 2025 (GLOBE NEWSWIRE) -- The "Molecular Biosensors Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ResearchAndMarkets.com ...

WEST LAFAYETTE, Ind. - Researchers have created an ultrasensitive biosensor that could open up new opportunities for early detection of cancer and "personalized medicine" tailored to the specific ...

The coronavirus disease 2019 (COVID-19) pandemic continues to be at the forefront of the world’s attention. COVID-19 is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

Graphene-based field-effect transistors, for example, could register the tiniest changes in the electronic properties caused by the molecules when they interact with this atomically thin layer.

VANCOUVER, BC and FRANKFURT, GERMANY / ACCESSWIRE / July 28, 2021 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the "Company") announces today that its acquisition target, ...

The acquisition positions XPhyto to be a leading Biosensor producer integrating thin film technology with 3a-diagnostics biosensor technology The acquisition of 3a, a German-based rapid point-of-care ...